Factors influencing the immediate and late outcome of cushing-disease treated by transsphenoidal surgery : A retrospective study by the european cushings-disease survey group
Bochicchio, D.; Losa, M.; Buchfelder, M.et al.
1995 • In Journal of Clinical Endocrinology and Metabolism, 80 (11), p. 3114-3120
Factors Influencing the Immediate and Late Outcome of Cushing's Disease Treated by Transsphenoidal Surgery - A Retrospective Study by the European Cushing's Disease Survey Group OK.pdf
pituitary adenoma; hypercortisolism; Cushing's disease; surgical treatment; transsphenoidal surgery
Abstract :
[en] Hypercortisolism attributable to hypersecretion of ACTH by a pituitary adenoma is an uncommon and progressively lethal disease. Because of its rarity, it has been difficult to collect a large series of patients in order to identify the prognostic factors influencing the outcome after transsphenoidal surgery. We conducted a multicenter, retrospective analysis of the early and late results of surgical treatment of Cushing's disease. Files of patients with Cushing's disease who underwent transsphenoidal surgery between 1975 and 1990 were collected from 25 institutions throughout Europe. Data from 668 of 716 patients were suitable for statistical analyses. Surgical mortality was 1.9%, and major morbidity occurred in 97 patients (14.5%). Clinical and biochemical remission of Cushing's disease after surgery occurred in 510 cases (76.3%). Identification of the tumor by neuroradiological imaging or at operation with histopathological corroboration was associated with remission of hypercortisolism. Recurrence of the disease occurred in 65 (12.7%) of 510 patients in remission after surgery at a mean time of 39.3 months (range 6-104 months). The distribution of the recurrences did not show any apparent plateau or cluster throughout the follow-up period. Low postoperative steroid levels, absence of cortisol response to CRH, and the need for long-term glucocorticoid substitution therapy were all associated with a high probability of long-term remission. Our study demonstrates that transsphenoidal surgery is a safe and effective treatment for patients with Cushing's disease. However, after successful surgery there is a steady increase in the percentage of recurrences, which continues with time. Patients who after operation had hypoadrenocorticism and needed long-term glucocorticoid substitution therapy had the lowest risk of relapse.
Factors influencing the immediate and late outcome of cushing-disease treated by transsphenoidal surgery : A retrospective study by the european cushings-disease survey group
Publication date :
November 1995
Journal title :
Journal of Clinical Endocrinology and Metabolism
ISSN :
0021-972X
eISSN :
1945-7197
Publisher :
Endocrine Society, Chevy Chase, United States - Maryland
Ambrosi B, Faglia G, and the Multicenter Pituitary Tumor Study Group, Lombardia Region. 1991 Epidemiology of pituitary tumors. In: Faglia G, Beck-Peccoz P, Ambrosi B, Travaglini P, Spada A, eds. Pituitary adenomas: new trends in basic and clinical research. Amsterdam: Excerpta Medica; 159-168.
Etxabe J, Vazquez JA. 1994 Morbidity and mortality in Cushing’s disease: an epidemiological approach. Clin Endocrinol (Oxf). 40: 479-484.
Melby JC. 1988 Therapy of Cushing’s disease: a consensus for pituitary microsurgery. Ann Intern Med. 109:445-446.
Welboum RB. 1985 Survival and causes of death after adrenalectomy for Cushing’s disease. Surgery. 97:16-20.
Lindholm J. 1992 Endocrine function in patients with Cushing’s disease before and after treatment. Clin Endocrinol (Oxf). 36:151-159.
Miller JW, Crapo L. 1993 The medical treatment of Cushing’s syndrome. Endocr Rev. 14:443-458.
Littiey MD, Shalet SM, Beardwell CG, Ahmed SR, Sutton ML. 1990 Long-term follow-up of low-dose external pituitary irradiation for Cushing’s disease. Clin Endocrinol (Oxf). 33:445-455.
Degerblad M, Rahn T, Bergstrand G, Thoren M. 1986 Long-term results of stereotactic radiosurgery to the pituitary gland in Cushing’s disease. Acta Endocrinol (Copenh). 112:310-314.
Burch W. 1983 A survey of results with transsphenoidal surgery in Cushing’s disease. N Engl J Med. 308:103-104.
Fahlbusch R, Buchfelder M, Müller OA. 1986 Transsphenoidal surgery for Cushing’s disease. J R Soc Med. 79:262-269.
Guilhaume B, Bertagna X, Thomsen M, et al. 1988 Transsphenoidal pituitary surgery for the treatment of Cushing’s disease: results in 64 patients and long-term follow-up studies. J Clin Endocrinol Metab. 66:1056-1064.
Pieters GFFM, Hermus ARMM, Meijer E, Smais AGH, Kloppenborg PWC. 1989 Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing’s disease. J Clin Endocrinol Metab. 69:1122-1126.
McCance DR, Mcllrath E, McNeill A, et al. 1989 Bilateral inferior petrosal sinus sampling as a routine procedure in ACTH-dependent Cushing’s syndrome. Clin Endocrinol (Oxf). 30:157-166.
Landolt AM, Schubiger O, Maurer R, Girard J. 1994 The value of inferior petrosal sinus sampling in diagnosis and treatment of Cushing’s disease. Clin Endocrinol (Oxf). 40:485-492.
Kaplan EL, Meier P. 1958 Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:457-481.
Dixon WJ. 1985 BMDP statistical software. Berkeley: University of California Press.
Mampalam TJ, Tyrrell JB, Wilson CB. 1988 Transsphenoidal microsurgery for Cushing’s disease: a report of 216 cases. Ann Intern Med. 109:487-493.
Tindall GT, Herring CJ, Clark RV, Adams DA, Watts NB. 1990 Cushing’s disease: results of transsphenoidal microsurgery with emphasis on surgical failures. J Neurosurg. 72:363-369.
McCance DR, Gordon DS, Fannin TF, et al. 1993 Assessment of endocrine function after transsphenoidal surgery for Cushing’s disease. Clin Endocrinol (Oxf). 38:79-86.
Salassa RM, Laws Jr ER, Carpenter PC Northcutt RC. 1978 Transsphenoidal removal of pituitary microadenoma in Cushing’s disease. Mayo Clin Proc. 53:24-28.
Hardy J. 1982 Cushing’s disease: 50 years later. Can J Neurol Sci. 9:375-380.
Thomas JP, Richards SH. 1983 Long-term results of radical hypophysectomy for Cushing’s disease. Clin Endocrinol (OxO. 19:629-636.
Tagliaferri A, Berselli M, Loli P. 1986 Transsphenoidal microsurgery for Cushing’s disease. Acta Endocrinol (Copenh). 113:5-11.
Chandler WF, Schteingart DE, Lloyd RV, McKeever PE, Ibarra-Perez G. 1987 Surgical treatment of Cushing’s disease. J Neurosurg. 66:204-212.
Nakane T, Kuwayama A, Watanabe M, et al. 1987 Long-term results of transsphenoidal adenomectomy in patients with Cushing’s dis-ease. Neurosurgery. 21:218-222.
Amott RD, Pesteil RG, McKelvie PA, Henderson JK, McNeill PM, Alford FP. 1990 A critical evaluation of transsphenoidal surgery in the treatment of Cushing’s disease: prediction of outcome. Acta Endocrinol (Copenh). 123:423-430.
Burke CW, Adams CBT, Esiri MM, Morris C, Bevan JS. 1990 Transsphenoidal surgery for Cushing’s disease: does what is removed determine the endocrine outcome? Clin Endocrinol (Oxf). 33:525-537.
Post KD, Habas JE. 1990 Comparison of long-term results between prolactin-secreting adenomas and ACTH-secreting adenomas. Can J Neurol Sci. 17:74-77.
Robert F, Hardy J. 1991 Cushing’s disease: a correlation of radiological, surgical and pathological findings with therapeutic results. Pathol Res Pract. 187:617-621.
Trainer PJ, Lawrie HS, Verheist J, et al. 1993 Transsphenoidal resection in Cushing’s disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf). 39:73-78.
Ram Z, Nieman LK, Cutler Jr GB, Chrousos GP, Doppman JL, Oldfield EH. 1994 Early repeat surgery for persistent Cushing’s disease. J Neurosurg. 80:37-45.
Müller OA, Stalla GK, von Werder K. 1983 Corticotropin releasing factor: a new tool for the differential diagnosis of Cushing’s syndrome.J Clin Endocrinol Metab. 57:227-229.
Oldfield EH, Doppman JL, Nieman LK, et al. 1991 Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing’s syndrome. N Engl J Med. 325: 897-905.
Oldfield EH, Chrousos GP, Schulte HM, et al. 1985 Preoperative lateralization of ACTH-secreting microadenomas by bilateral and simultaneous inferior petrosal sinus sampling. N Engl J Med. 312: 100-103.
Davis DH, Laws Jr ER, Ilstrup DM, et al. 1993 Results of surgical treatment for growth hormone-secreting pituitary adenomas.J Neurosurg. 79:70-75.
Charpentier G, de Plunkett T, Jedynak P, et al. 1985 Surgical treatment of prolactinomas: short-and long-term results, prognostic factors. Horm Res. 22:222-227.
Magiakou MA, Mastorakos G, Oldfield EH, et al. 1994 Cushing’s syndrome in children and adolescents: presentation, diagnosis, and therapy. N Engl J Med. 331:629 -636.
Avgerinos PC, Chrousos GP, Nieman LK, Oldfield EH, Loriaux DL, Cutler Jr GB. 1987 The corticotropin-releasing hormone test in the postoperative evaluation of patients with Cushing’s disease. J Clin Endocrinol Metab. 65:906-913.
Schrell U, Fahlbusch R, Buchfelder M, Riedl S, Stalla GK, Müller OA. 1987 Corticotrophin-releasing hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing’s disease. J Clin Endocrinol Metab. 64:1150-1159.
Fitzgerald PA, Aron DC, Findling JW, et al. 1982 Cushing’s disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin. J Clin Endocrinol Metab. 54:413-422.
